|
Volumn 16, Issue , 2003, Pages 217-245
|
Advances in the use of naltrexone: an integration of preclinical and clinical findings.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUGS USED IN THE TREATMENT OF ADDICTION;
NALTREXONE;
NARCOTIC ANTAGONIST;
ALCOHOLISM;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
GENETIC PREDISPOSITION;
GENETICS;
HUMAN;
MOTIVATION;
PSYCHOLOGICAL ASPECT;
RANDOMIZED CONTROLLED TRIAL;
RECURRENT DISEASE;
REVIEW;
ALCOHOL DETERRENTS;
ALCOHOLISM;
GENETIC PREDISPOSITION TO DISEASE;
HUMANS;
MOTIVATION;
NALTREXONE;
NARCOTIC ANTAGONISTS;
RANDOMIZED CONTROLLED TRIALS;
RECURRENCE;
|
EID: 0037264509
PISSN: 0738422X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (59)
|
References (175)
|